ACLX vs VLTO · rev $107.9M vs P/E 29, rev $5.50B
Arcellx Inc (ACLX) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
ACLX currently screens at market cap $6.73B. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the ACLX and VLTO stock pages for the full models.
Not investment advice.